HOME
COMPANY PROFILE
MANAGEMENT
INVESTOR RELATIONS
OVERVIEW
CORPORATE GOVERNANCE
STOCK TRANSFER AGENT
SEC FILINGS
SECTION 16 FORMS
PRESENTATIONS/EVENTS
PUBLICATIONS
PRESS RELEASES
ANNUAL REPORTS
CONTACT
Publications
To view our documents, you must use software that is capable of opening PDF (portable document format) files. Our documents are compatible with Adobe
®
v6.0 and higher.
Nasulin
TM
(Intranasal Recombinant Human Insulin)
November 2, 2009 | 37 pages
Recent News
MARCH 03, 2010
CPEX PHARMACEUTICALS REPORTS 2009 FOURTH-QUARTER AND YEAR-END FINANCIAL RESULTS
FEBRUARY 18, 2010
CPEX PHARMACEUTICALS ANNOUNCES ARCADIA OPPORTUNITY MASTER FUND WITHDRAWS PREVIOUSLY STATED INTENTION TO SUBMIT SHAREHOLDER PROPOSALS AND NOMINATE DIRECTOR SLATE AT 2010 ANNUAL MEETING
ARCADIA RETAINS INTENT TO NOMINATE ONE DIRECTOR
FEBRUARY 01, 2010
CPEX PHARMACEUTICALS ANNOUNCES APPOINTMENT OF NEW CHIEF SCIENTIFIC OFFICER
